Registrants1
Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.
Suven Pharmaceuticals Limited
861468675
Manufacturing Establishments1
FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited
677604288
Products2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Chloroquine Phosphate
Product Details
NDC Product Code
68022-0265Application Number
ANDA214756Marketing Category
ANDA (C73584)Route of Administration
ORALEffective Date
January 9, 2024ChloroquineActive
Code: 6E17K3343PClass: ACTIBQuantity: 500 mg in 1 1
Chloroquine Phosphate
Product Details
NDC Product Code
68022-0264Application Number
ANDA214756Marketing Category
ANDA (C73584)Route of Administration
ORALEffective Date
January 9, 2024ChloroquineActive
Code: 6E17K3343PClass: ACTIBQuantity: 500 mg in 1 1